Product Details
Product Name:
Xl-281 |
CAS No.:
870603-16-0 |
Purity:
98.60% |
Supply Ability:
10g |
Release date:
2024/11/11 |
Product Introduction
Bioactivity
名稱 | Xl-281 |
描述 | Xl-281 (BMS-908662) is a BRAF inhibitor with anti-tumor activity for the study of colorectal cancer and melanoma. |
存儲條件 | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
相關(guān)產(chǎn)品 | Regorafenib monohydrate | Doramapimod | Vemurafenib | Sorafenib | Regorafenib | Dabrafenib | Sorafenib tosylate | PLX-4720 | LY3009120 | GW 441756 |
相關(guān)庫 | 經(jīng)典已知活性庫 | 疼痛相關(guān)化合物庫 | 已知活性化合物庫 |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
-
CAS:1235032-75-3
$74.00 / 1mg
-
CAS:705946-27-6
$35.00 / 1mg
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$198.00/2mg |
VIP1Y
|
TargetMol Chemicals Inc.
|
2024-10-28 |
|
$15.00/1KG |
|
Zhuozhou Wenxi import and Export Co., Ltd
|
2021-06-26 |